4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-18-058026
Chief Executive Officer sold 81,500 shares at an average $14.39 ($1,172,705)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2018-11-09 | Sale | −76,200 | $14.35 | $1,093,470 | 1,727,755 | D: show line 1 in the form |
| Anzalone Christopher Richard Chief Executive Officer | 2018-11-09 | Sale | −5,300 | $14.95 | $79,235 | 1,722,455 | D: show line 2 in the form |
| Open-market sales · 81,500 sh · avg $14.39 · $1,172,705 | |||||||
Loading xslF345X03/doc4.xml…